Pembrolizumab Asociado a Quimioterapia Neoadyuvante en Cáncer de Mama Triple Negativo Temprano Pablo Esteban Repullo Soto, Jamile Camacho Neira, Carolina Barriga Schneeberger, Pía Pincheira Torán, Juan Cristóbal Celis Carrasco, Eugenio Román Lucero 2025-06-30
Application of three prognostic models in T1N0M0 breast cancer César Sánchez R., Daniela Maldonado J., Jaime Jans B., Francisco Domínguez C., Héctor Galindo A., Mauricio Camus A., David Oddo B., Lidia Medina A., Francisco Acevedo C. 2018-07-17
Bilateral mastectomy with immediate reconstruction as a treatment for breast cancer: Is it the cause of delays in adjuvant therapies? Marta Allué Cabañuz 2020-03-09